9,10‐Anthraquinone hinders β‐aggregation: How does a small molecule interfere with Aβ‐peptide amyloid fibrillation?

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Protein Science

• Publication date

  2009-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/pro.87PMID 19309732PMCID PMC2762591
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amyloid-ss Dynamics Correlate with Neurological Status in the Injured Human Brain

  2009cited by this paper
• Cognitive-performance recovery of Alzheimer's disease model mice by modulation of early soluble amyloidal assemblies.

  2009cited by this paper
• CE can identify small molecules that selectively target soluble oligomers of amyloid β protein and display antifibrillogenic activity

  2009cited by this paper
• Insights into stability and toxicity of amyloid-like oligomers by replica exchange molecular dynamics analyses.

  2008cited by this paper
• Small-molecule inhibitors of islet amyloid polypeptide fibril formation.

  2008cited by this paper
• Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

  2008cited by this paper
• Inhibition of Amyloid Fibrillization of Hen Egg‐White Lysozymes by Rifampicin and p‐Benzoquinone

  2008cited by this paper
• Amyloid-β Dynamics Correlate with Neurological Status in the Injured Human Brain

  2008cited by this paper
• Rifampicin does not prevent amyloid fibril formation by human islet amyloid polypeptide but does inhibit fibril thioflavin-T interactions: implications for mechanistic studies of beta-cell death.

  2008cited by this paper
• Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct*

  2007cited by this paper
• IAPP mimic blocks Abeta cytotoxic self-assembly: cross-suppression of amyloid toxicity of Abeta and IAPP suggests a molecular link between Alzheimer's disease and type II diabetes.

  2007cited by this paper
• Pathways and intermediates of amyloid fibril formation.

  2007cited by this paper
• Structural Reorganisation and Potential Toxicity of Oligomeric Species Formed during the Assembly of Amyloid Fibrils

  2007cited by this paper
• Hydrophobic cooperativity as a mechanism for amyloid nucleation.

  2007cited by this paper
• Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis

  2007cited by this paper
• Inhibition of amyloid fibrillation of lysozyme by indole derivatives − possible mechanism of action

  2007cited by this paper
• New insights into the mechanism of Alzheimer amyloid-beta fibrillogenesis inhibition by N-methylated peptides.

  2007cited by this paper
• Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

  2007cited by this paper
• Insight Into the Kinetic of Amyloid β (1–42) Peptide Self‐Aggregation: Elucidation of Inhibitors’ Mechanism of Action

  2007cited by this paper
• Inhibition of amyloid fibril formation and cytotoxicity by hydroxyindole derivatives.

  2006cited by this paper
• N-Methylated Peptide Inhibitors of β-Amyloid Aggregation and Toxicity. Optimization of the Inhibitor Structure†

  2006cited by this paper
• Interpreting the aggregation kinetics of amyloid peptides.

  2006cited by this paper
• Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse model

  2006cited by this paper
• A molecular dynamics approach to the structural characterization of amyloid aggregation.

  2006cited by this paper
• A century-old debate on protein aggregation and neurodegeneration enters the clinic

  2006influential reference
• Structures of soluble amyloid oligomers from computer simulations

  2006cited by this paper
• Computational models for the prediction of polypeptide aggregation propensity.

  2006cited by this paper
• Anion–π Interactions in Cyanuric Acids: A Combined Crystallographic and Computational Study

  2005cited by this paper
• Anthraquinones Inhibit Tau Aggregation and Dissolve Alzheimer's Paired Helical Filaments in Vitro and in Cells*

  2005cited by this paper
• Prediction of aggregation rate and aggregation‐prone segments in polypeptide sequences

  2005cited by this paper
• Sequence dependence of amyloid fibril formation: insights from molecular dynamics simulations.

  2005cited by this paper
• Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's β‐amyloid

  2005cited by this paper
• Molecular dynamics simulations of Alzheimer's beta-amyloid protofilaments.

  2005cited by this paper
• Anion-pi interactions in cyanuric acids: a combined crystallographic and computational study.

  2005cited by this paper
• Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions.

  2004cited by this paper
• Replica exchange molecular dynamics simulations of amyloid peptide aggregation.

  2004cited by this paper
• Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis.

  2004cited by this paper
• Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro

  2004cited by this paper
• Kinetic control of dimer structure formation in amyloid fibrillogenesis.

  2004cited by this paper
• Direct observation of Abeta amyloid fibril growth and inhibition.

  2004cited by this paper
• Direct Observation of Aβ Amyloid Fibril Growth and Inhibition

  2004cited by this paper
• Cation-π versus anion-π interactions: a comparative ab initio study based on energetic, electron charge density and aromatic features

  2004cited by this paper
• Dissecting the Assembly of Aβ16–22 Amyloid Peptides into Antiparallel β Sheets

  2003cited by this paper
• Dissecting the assembly of Abeta16-22 amyloid peptides into antiparallel beta sheets.

  2003cited by this paper
• Electrostatic interaction of pi-acidic amides with hydrogen-bond acceptors.

  2003cited by this paper
• Interactions with aromatic rings in chemical and biological recognition.

  2003cited by this paper
• The role of side-chain interactions in the early steps of aggregation: Molecular dynamics simulations of an amyloid-forming peptide from the yeast prion Sup35

  2003cited by this paper
• Therapeutic approaches to protein-misfolding diseases

  2003cited by this paper
• Stabilities and conformations of Alzheimer's beta -amyloid peptide oligomers (Abeta 16-22, Abeta 16-35, and Abeta 10-35): Sequence effects.

  2002cited by this paper
• Evaluation of a fast implicit solvent model for molecular dynamics simulations

  2002cited by this paper
• Stabilities and conformations of Alzheimer's β-amyloid peptide oligomers (Aβ16–22, Aβ16–35, and Aβ10–35): Sequence effects

  2002cited by this paper
• Trimethyl isocyanurate and triethyl isocyanurate.

  1998cited by this paper
• Temperature Dependence of the Rigid-Body Motion of Anthraquinone

  1998cited by this paper
• Inhibitors of Aβ Peptide Aggregation as Potential anti-Alzheimer Agents

  1997cited by this paper
• Rifampicin inhibits the toxicity of pre-aggregated amyloid peptides by binding to peptide fibrils and preventing amyloid-cell interaction.

  1997cited by this paper
• Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand (*)

  1996cited by this paper
• Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution

  1993cited by this paper
• Determination of net atomic charges using a modified partial equalization of orbital electronegativity method. 1. Application to neutral molecules as models for polypeptides

  1990cited by this paper
• CHARMM: A program for macromolecular energy, minimization, and dynamics calculations

  1983cited by this paper

• Behavioral, Histopathological, and Biochemical Implications of Aloe Emodin in Copper-Aβ-Induced Alzheimer’s Disease-like Model Rats

  2026cites this paper
• Chemical Strategies to Modulate Amyloidogenesis Associated with Neurodegenerative Diseases.

  2026cites this paper
• YIAD-0501 directly dissociates aggregates of full-length and N-terminal pyroglutamate-modified forms of Aβ.

  2026cites this paper
• Luteoloside inhibits Aβ1-42 fibrillogenesis, disintegrates preformed fibrils, and alleviates amyloid-induced cytotoxicity.

  2024cites this paper
• Alizarin attenuates oxidative stress-induced mitochondrial damage in vascular dementia rats by promoting TRPM2 ubiquitination and proteasomal degradation via Smurf2.

  2024cites this paper
• Anti-Glycation, Anti-β-Amyloid Aggregation, and Antioxidant Effect of Cassia Seed-Derived Secondary Metabolites

  2023cites this paper
• Quinones as Neuroprotective Agents

  2023cites this paper
• Yet another in vitro evidence that natural compounds introduced by diet have anti-amyloidogenic activities and can counteract neurodegenerative disease depending on aging

  2023cites this paper
• Thioxanthenone-based derivatives as multitarget therapeutic leads for Alzheimer's disease.

  2023cites this paper
• Inhibition of β-Amyloid Aggregation in Alzheimer’s Disease: The Key Role of (Pro)electrophilic Warheads

  2022cites this paper
• Solid state synthesis of bispyridyl-ferrocene conjugates with unusual site selective 1,4-Michael addition, as potential inhibitor and electrochemical probe for fibrillation in amyloidogenic protein

  2022cites this paper
• Tau protein aggregation: key features to improve drug discovery screening.

  2022cites this paper
• Celastrol regulates the oligomeric state and chaperone activity of αB-crystallin linked with protein homeostasis in the lens

  2022cites this paper
• A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE)

  2022cites this paper
• Multitarget Biological Profiling of New Naphthoquinone and Anthraquinone-Based Derivatives for the Treatment of Alzheimer’s Disease

  2021cites this paper
• Humanin Blocks the Aggregation of Amyloid- β Induced by Acetylcholinesterase, an Effect Abolished in the Presence of IGFBP-3

  2021cites this paper
• Inhibitory activities of anthraquinone and xanthone derivatives against transthyretin amyloidogenesis.

  2021cites this paper
• Alizarin and Purpurin from Rubia tinctorum L. Suppress Insulin Fibrillation and Reduce the Amyloid-Induced Cytotoxicity.

  2021cites this paper
• The Potential of 9,10-Anthraquinone in Inhibiting Human Cancer Cells Growth

  2021cites this paper
• Pouteria sapota (Red Mamey Fruit): Chemistry and Biological Activity of Carotenoids.

  2021cites this paper
• Journey on Naphthoquinone and Anthraquinone Derivatives: New Insights in Alzheimer’s Disease

  2021cites this paper
• Homobivalent Lamellarin-Like Schiff Bases: In Vitro Evaluation of Their Cancer Cell Cytotoxicity and Multitargeting Anti-Alzheimer’s Disease Potential

  2021cites this paper
• Sensing of nutrients by CPT1C controls SAC1 activity to regulate AMPA receptor trafficking

  2020cites this paper
• Nanostructures Formed by Custom-Made Peptides Based on Amyloid Peptide Sequences and Their Inhibition by 2-Hydroxynaphthoquinone

  2020cites this paper
• Novel isatin thiosemicarbazone derivatives as potent inhibitors of β-amyloid peptide (Αβ) aggregation and toxicity.

  2020cites this paper
• Humanin blocks aggregation of amyloid beta induced by acetylcholinesterase, an effect abolished in the presence of IGFBP-3.

  2020cites this paper
• Mechanism of rutin mediated inhibition of insulin amyloid formation and protection of Neuro-2a cells from fibril-induced apoptosis

  2020cites this paper
• Discovery of small molecules for the treatment of Alzheimer’s disease

  2020cites this paper
• Inhibition of amyloid fibrillation of γD-crystallin model peptide by the cochineal Carmine.

  2020cites this paper
• Computational Evaluation of Interaction Between Curcumin Derivatives and Amyloid-β Monomers and Fibrils: Relevance to Alzheimer’s Disease

  2020cites this paper
• Synthesis and simulation of new cyclodextrin derivatives breaker for Aß42

  2020cites this paper
• Interaction of amyloid beta with humanin and acetylcholinesterase is modulated by ATP

  2020cites this paper
• Physicochemical Insights into Role of Drug Functionality in Fibrillation Inhibition of Bovine Serum Albumin.

  2020cites this paper
• Carotenoids as Novel Therapeutic Molecules Against Neurodegenerative Disorders: Chemistry and Molecular Docking Analysis

  2019cites this paper
• Naphthoquinone Tryptophan Hybrids: A Promising Small Molecule Scaffold for Mitigating Aggregation of Amyloidogenic Proteins and Peptides

  2019cites this paper
• Anthraquinones and autophagy - Three rings to rule them all?

  2019cites this paper
• Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes.

  2019cites this paper
• On the role of synthesized hydroxylated chalcones as dual functional amyloid-β aggregation and ferroptosis inhibitors for potential treatment of Alzheimer's disease.

  2019cites this paper
• Assessment of novel azaanthraquinone derivatives as potent multi-target inhibitors of inflammation and amyloid-β aggregation in Alzheimer's disease.

  2019cites this paper
• Resveratrol modulates fibrillogenesis in a poly‑l‑lysine peptide.

  2019cites this paper
• A Prospective Repurposing of Dantrolene as a Multitarget Agent for Alzheimer’s Disease

  2019cites this paper
• Molecular Dynamics Simulations of Small-Molecule Inhibitors of β-Amyloid Aggregation

  2019cites this paper
• A computational approach to get insights into multiple faces of additives in modulation of protein aggregation pathways.

  2019cites this paper
• Stabilizing proteins to prevent conformational changes required for amyloid fibril formation

  2018cites this paper
• Controlling compartmentalization by non-membrane-bound organelles

  2018cites this paper
• Insights into Structure-Activity Relationships of 3-Arylhydrazonoindolin-2-One Derivatives for Their Multitarget Activity on β-Amyloid Aggregation and Neurotoxicity

  2018cites this paper
• Is there correlation between Aβ-heme peroxidase activity and the peptide aggregation state? A literature review combined with hypothesis.

  2017cites this paper
• Capsicum annuum var. grossum (Bell Pepper) Inhibits β-Secretase Activity and β-Amyloid1–40 Aggregation

  2017cites this paper
• Multicomponent, fragment-based synthesis of polyphenol-containing peptidomimetics and their inhibiting activity on beta-amyloid oligomerization.

  2017cites this paper
• Aloe emodin, an anthroquinone from Aloe vera acts as an anti aggregatory agent to the thermally aggregated hemoglobin.

  2017cites this paper
• Inhibition of amyloid oligomerization into different supramolecular architectures by small molecules: mechanistic insights and design rules.

  2017cites this paper
• TCM, brain function and drug space.

  2016cites this paper
• Pharmacological Chaperones: Design and Development of New Therapeutic Strategies for the Treatment of Conformational Diseases.

  2016cites this paper
• 8‐Aminomethyl‐7‐hydroxy‐4‐methylcoumarins as Multitarget Leads for Alzheimer's Disease

  2016cites this paper
• Atomistic mechanism of polyphenol amyloid aggregation inhibitors: molecular dynamics study of Curcumin, Exifone, and Myricetin interaction with the segment of tau peptide oligomer

  2015cites this paper
• Alzheimer's protective A2T mutation changes the conformational landscape of the Aβ₁₋₄₂ monomer differently than does the A2V mutation.

  2015cites this paper
• 1,2‐Diaryl‐2‐hydroxyiminoethanones as Dual COX‐1 and β‐Amyloid Aggregation Inhibitors: Biological Evaluation and In Silico Study

  2015cites this paper
• Computer-Aided Structure-Based Design of Multitarget Leads for Alzheimer's Disease

  2015cites this paper
• Nonpeptide neurotrophic agents useful in the treatment of neurodegenerative diseases such as Alzheimer's disease.

  2015cites this paper
• Multitarget Therapeutic Leads for Alzheimer’s Disease: Quinolizidinyl Derivatives of Bi‐ and Tricyclic Systems as Dual Inhibitors of Cholinesterases and β‐Amyloid (Aβ) Aggregation

  2015cites this paper
• Study on the inter- and intra-peptide salt-bridge mechanism of Aβ23-28 oligomer interaction with small molecules: QM/MM method.

  2015cites this paper
• Two diseases, one approach: multitarget drug discovery in Alzheimer's and neglected tropical diseases

  2014cites this paper
• Targeted studies on the interaction of nicotine and morin molecules with amyloid β-protein

  2014cites this paper
• On the search for multitarget inhibitors for BACE‐1 and other pharmacological targets of Alzheimer's Disease

  2014cites this paper
• Effects of several quinones on insulin aggregation

  2014cites this paper
• Polyphenols as Therapeutic Molecules in Alzheimer’s Disease Through Modulating Amyloid Pathways

  2014cites this paper
• Recent Development of Multifunctional Agents as Potential Drug Candidates for the Treatment of Alzheimer's Disease

  2014cites this paper
• Interaction of Amyloid Inhibitor Proteins with Amyloid Beta Peptides: Insight from Molecular Dynamics Simulations

  2014cites this paper
• Effects of several quinones on insulin

  2014cites this paper
• Naturally occurring polyphenolic inhibitors of amyloid beta aggregation.

  2014cites this paper
• The Atomic Level Interaction of Polyphenols with the Aβ Oligomer Aggregate, A Molecular Dynamic Guidance for Rational Drug Design

  2014cites this paper
• Implicit Solvent Models and Stabilizing Effects of Mutations and Ligands on the Unfolding of the Amyloid β-Peptide Central Helix.

  2013cites this paper
• Ferulic Acid Inhibits the Transition of Amyloid-β42 Monomers to Oligomers but Accelerates the Transition from Oligomers to Fibrils

  2013cites this paper
• Investigating the binding interactions of galantamine with β-amyloid peptide.

  2013cites this paper
• Evidence of π‐stacking interactions in the self‐assembly of hIAPP22‐29

  2013cites this paper
• Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs

  2013cites this paper
• Anthraquinone-2-sulfonic acid (AQ2S) is A Novel Neurotherapeutic Agent

  2013cites this paper
• Potential synergy between tau aggregation inhibitors and tau chaperone modulators

  2013cites this paper
• The effect of fulvic acid on pre- and postaggregation state of Aβ(17-42): molecular dynamics simulation studies.

  2013cites this paper
• Quinones bearing non-steroidal anti-inflammatory fragments as multitarget ligands for Alzheimer's disease.

  2013cites this paper
• Methylations of tryptophan-modified naphthoquinone affect its inhibitory potential toward Aβ aggregation.

  2013cites this paper
• Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model.

  2012cites this paper
• Flexibility and binding affinity in protein–ligand, protein–protein and multi-component protein interactions: limitations of current computational approaches

  2012cites this paper
• Explicit solvent molecular dynamics simulations of Aβ peptide interacting with ibuprofen ligands.

  2012cites this paper
• Rutin inhibits β-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines.

  2012cites this paper
• Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase.

  2012cites this paper
• Molecular Modeling of the Amyloid β-Peptide: Understanding the Mechanism of Alzheimer's Disease and the Potential for Therapeutic Intervention

  2012cites this paper
• The role of molecular simulations in the development of inhibitors of amyloid β-peptide aggregation for the treatment of Alzheimer's disease.

  2012cites this paper
• Generic inhibition of amyloidogenic proteins by two naphthoquinone–tryptophan hybrid molecules

  2012cites this paper
• Photocontrol of reversible amyloid formation with a minimal-design peptide.

  2012cites this paper
• Design , Synthesis , and Structure − Activity Relationship of N ‐ Arylnaphthylamine Derivatives as Amyloid Aggregation Inhibitors

  2012cites this paper
• Structures of Aβ17-42 trimers in isolation and with five small-molecule drugs using a hierarchical computational procedure.

  2012cites this paper
• Disordered Binding of Small Molecules to Aβ(12–28)*

  2011cites this paper
• Delineation of folding pathways of a β-sheet miniprotein.

  2011cites this paper
• Self-assembly Of Amyloid Aggregates Simulated With Molecular Dynamics

  2011cites this paper
• Insight into Amyloid Structure Using Chemical Probes

  2011cites this paper
• Naproxen interferes with the assembly of Aβ oligomers implicated in Alzheimer's disease.

  2011cites this paper
• Synthesis and biophysical evaluation of arylhydrazono-1H-2-indolinones as β-amyloid aggregation inhibitors.

  2011cites this paper
• Resveratrol inhibits the formation of multiple-layered β-sheet oligomers of the human islet amyloid polypeptide segment 22-27.

  2011cites this paper
• Structural basis for inhibiting β-amyloid oligomerization by a non-coded β-breaker-substituted endomorphin analogue.

  2011cites this paper